-+ 0.00%
-+ 0.00%
-+ 0.00%

Biomerica inFoods IBS real-world effectiveness study accepted for DDW 2026 presentation

PUBT·04/29/2026 12:19:57
Listen to the news
Biomerica inFoods IBS real-world effectiveness study accepted for DDW 2026 presentation
  • Biomerica reported acceptance of real-world clinical effectiveness data for its inFoods IBS diagnostic-guided therapy for poster presentation at Digestive Disease Week 2026 in Chicago.
  • Results have not yet been presented; data will be released under conference embargo beginning 12:01 a.m. CDT on May 2, 2026.
  • Study conclusion indicates the guided elimination diet approach reduced abdominal symptoms in people with irritable bowel syndrome.
  • Work was conducted by investigators from University of Michigan, with participation from Cleveland Clinic, extending prior controlled trial findings published in Gastroenterology in June 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomerica Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604290819PRIMZONEFULLFEED9709292) on April 29, 2026, and is solely responsible for the information contained therein.